Indeed, we could not rule out the possibility that some key parameters, such as glucose, insulin, and glucagon, may attenuate the relationship between the ANGPTL4 and SUA-associated dyslipidemia. The gene discussed is ANGPTL4; the disease is metabolic syndrome.